US Metastatic Cancer Treatment Market Trends 2034: Advances in Targeted Therapies and Immunotherapy
US Metastatic Cancer Treatment Market expansion is driven by the growing use of immunotherapy and targeted medicines. Treatment options are increasingly selected according to cancer type, molecular biomarkers, previous therapies, and individual patient characteristics. The Metastatic Cancer Treatment Market was valued at US$ 66.15 billion in 2025 and is projected to reach US$ 158.86 billion by...
0 Commentarios 0 Acciones 124 Views 0 Vista previa